Literature DB >> 2205377

K-ras activation in neoplasms of the human female reproductive tract.

T Enomoto1, M Inoue, A O Perantoni, N Terakawa, O Tanizawa, J M Rice.   

Abstract

The role of cellular oncogenes in the development of epithelial tumors of the human female reproductive tract has not previously been extensively studied. DNAs isolated from ten human uterine, 13 ovarian, and four cervical neoplasms and from three cell lines derived from endometrial adenocarcinoma were investigated by dot blot hybridization after polymerase chain reaction amplification of ras gene sequences and in some cases by NIH 3T3 transfection. Transforming activity was found in two of nine endometrial adenocarcinomas, but none of seven ovarian carcinomas and none of four cervical carcinomas showed transforming activity. K-ras sequences with a GGT----GAT mutation in codon 12 were demonstrated in both transformants derived from endometrial carcinoma. K-ras codon 12 mutations were similarly detected in six of 13 endometrial carcinomas (one GAT and GCT, one GTT and GCT, two GAT, two GTT) and two of 13 ovarian tumors (GAT and GCT, GAT), both mucinous adenocarcinomas. Point mutation of K-ras in codon 12 is thus comparably frequent in uterine endometrial carcinomas and in colorectal carcinomas and may have similar significance as an event that contributes to progression of these tumors. Cervical carcinomas and ovarian tumors in general, with the possible exception of mucinous adenocarcinoma of the ovary, do not appear to have this characteristic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205377

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Characterization of murine cell lines from diethylstilbestrol-induced uterine endometrial adenocarcinomas.

Authors:  C D Hébert; S Endo; K S Korach; J Boyd; J C Barrett; J A McLachlan; R R Newbold
Journal:  In Vitro Cell Dev Biol       Date:  1992-05

2.  Biomarkers in endometrial cancer: Possible clinical applications (Review).

Authors:  Kouji Banno; Iori Kisu; Megumi Yanokura; Kosuke Tsuji; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Lett       Date:  2012-03-26       Impact factor: 2.967

3.  Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.

Authors:  John Farley; Michael W Sill; Michael Birrer; Joan Walker; Russell J Schilder; J Tate Thigpen; Robert L Coleman; Brigitte E Miller; Peter G Rose; Heather A Lankes
Journal:  Gynecol Oncol       Date:  2011-02-16       Impact factor: 5.482

4.  Isolation of side population cells from endometrial cancer cells using a violet laser diode.

Authors:  Satoshi Tomiyasu; Tomoyuki Miyamoto; Michihiro Mori; Takahiro Yaguchi; Hiromasa Yakushiji; Setsuyo Ohno; Yasuyuki Miyake; Takuya Sakaguchi; Masatsugu Ueda; Eiji Ohno
Journal:  Hum Cell       Date:  2013-10-04       Impact factor: 4.174

5.  Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.

Authors:  J J O'Leary; R J Landers; I Silva; V Uhlmann; M Crowley; I Healy; K Luttich
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

6.  The genomics and genetics of endometrial cancer.

Authors:  Andrea J O'Hara; Daphne W Bell
Journal:  Adv Genomics Genet       Date:  2012-03

7.  K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.

Authors:  T Enomoto; C M Weghorst; M Inoue; O Tanizawa; J M Rice
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

8.  Changes of silver-stained nucleolar organizer regions in mouse endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17 beta-oestradiol.

Authors:  K Niwa; Y Yokoyama; T Furui; T Tanaka; H Mori; H Mori; T Tamaya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Authors:  D Chatterjee; C J Liu; D Northey; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 10.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.

Authors:  Sigurd F Lax
Journal:  Virchows Arch       Date:  2004-01-28       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.